Skip to main content
. Author manuscript; available in PMC: 2021 Jun 17.
Published in final edited form as: J Agric Food Chem. 2020 Jun 4;68(24):6576–6587. doi: 10.1021/acs.jafc.0c01475

Table 1.

IC50 Values (in µg/mL) of Anti-proliferation Activities of ME, its Fractions and Key Active Components (MGN, HNK, MHNK), Individually and in Different Ratios in Oral Cancer Cell Lines (Cal-27 and SCC-9) Based on the MTT Assay Run in Triplicate.

Cell lines Reagent Treatment period (hr)
24 48 72 96
Cal-27
MEa 36.3 ± 2.6 25.7 ± 2.3 14.2 ± 2.5 8.2 ± 1.9
MGN 20.7 ± 1.8* 11.9 ± 0.6* 5.1 ± 0.6* 4.0 ± 0.8*
HNK 20.8 ± 1.3* 12.2 ± 1.0* 6.6 ± 0.6* 4.2 ± 0.4*
MHNK 14.5 ± 0.9* 7.7 ± 0.8* 5.6 ± 1.4* 3.2 ± 0.3*
Fraction 1 >100*
Fraction 2 72.1 ± 2.3*
Fraction 3 61.8 ± 9.4*
Fraction Ab 22.5 ± 1.4
1:1:1 (MGN:HNK:MHNK) 4.8 ± 0.2*
1:2:6 (MGN:HNK:MHNK) 3.8 ± 0.2*
1:2:3 (MGN:HNK:MHNK) 3.9 ± 0.3*
5-FU (positive control) 0.4 ± 0.1*

SCC-9
MEa 14.4 ± 2.9
MGN 7.9 ± 0.4*
HNK 5.5 ± 0.6*
MHNK 5.2 ± 1.3*
Fraction 1 > 100*
Fraction 2 > 100*
Fraction 3 99.5 ± 0.6*
Fraction Ab 19.6 ± 1.7
5-FU (positive control) 1.9 ± 0.4*
a

Ratio of three key active ingredients in ME was 1.0 : 1.4 : 1.2 (MGN : HNK : MHNK)

b

Ratio of compounds in Fraction A was 1.0 : 0.82 : 0.28 (MGN : HNK : MHNK)

*

indicates significant different with the respective the respective IC50 value of ME. (p < 0.05). Statistical analysis was performed using one-way ANOVA with Tukey similarity test.